At Veebot, we are revolutionizing venipuncture through automation, medical imaging and machine precision. As you may know, venipuncture is one of the most common procedures around with 1.4B operations done a year in the US alone. It also happens to be a painful process for all involved -- from the patient that requires multiple painful attempts, to the stressed out nurse that risks a deadly needlestick injury, or the medical facility that has to pay for all the wasted time, materials, and procedures. At an estimated global market size of $1.9B annually, we believe this is a problem worth solving. We have gained initial traction through winning second place at the Stanford BASES 150k challenge, graduation from the Stanford hardware accelerator Forge, and being admitted into the StartX program. Currently, we are in the process of raising a round of financing as well as growing our board of advisers.